Literature DB >> 10674647

Molecular phylogeny of Burkholderia pseudomallei.

T L Pitt1, S Trakulsomboon, D A Dance.   

Abstract

In terms of population structure, the species Burkholderia pseudomallei contains both clonal and non-clonal elements. By indexing variation in rRNA loci using the restriction endonuclease BamHI, we found that two ribotypes (types 1 and 3) are predominant in nature. Ribotype 3 is prevalent in Asian countries while ribotype 1 is more widespread. Some disease association was suggested for 4 ribotypes and strains of ribotype 4 were markedly associated with a fatal outcome. DNA macrorestriction (XbaI) profiles resolved by pulsed-field gel electrophoresis revealed great heterogeneity within the prevalent ribotypes and these profiles appeared to be reliable strain markers. Arabinose environmental strains were characterised by BamHI ribotypes that were markedly distinct form clinical and environmental isolates of the arabinose negative phenotype.

Mesh:

Substances:

Year:  2000        PMID: 10674647     DOI: 10.1016/s0001-706x(99)00068-6

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  12 in total

1.  Isolates of Burkholderia pseudomallei from Northern Australia are distinct by multilocus sequence typing, but strain types do not correlate with clinical presentation.

Authors:  Allen C Cheng; Daniel Godoy; Mark Mayo; Daniel Gal; Brian G Spratt; Bart J Currie
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

2.  Molecular genetic basis of ribotyping.

Authors:  Valérie Bouchet; Heather Huot; Richard Goldstein
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

Review 3.  Human Melioidosis.

Authors:  I Gassiep; M Armstrong; R Norton
Journal:  Clin Microbiol Rev       Date:  2020-03-11       Impact factor: 26.132

4.  Multilocus sequence typing of historical Burkholderia pseudomallei isolates collected in Southeast Asia from 1964 to 1967 provides insight into the epidemiology of melioidosis.

Authors:  Roberta L McCombie; Richard A Finkelstein; Donald E Woods
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

Review 5.  Melioidosis: epidemiology, pathophysiology, and management.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

6.  Recurrent melioidosis in patients in northeast Thailand is frequently due to reinfection rather than relapse.

Authors:  Bina Maharjan; Narisara Chantratita; Mongkol Vesaratchavest; Allen Cheng; Vanaporn Wuthiekanun; Wirongrong Chierakul; Wipada Chaowagul; Nicholas P J Day; Sharon J Peacock
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

7.  Comparison of rapid, automated ribotyping and DNA macrorestriction analysis of Burkholderia pseudomallei.

Authors:  Timothy J J Inglis; Lyn O'Reilly; Niki Foster; Adele Clair; Judy Sampson
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

8.  Use of 16S rRNA gene sequencing for rapid identification and differentiation of Burkholderia pseudomallei and B. mallei.

Authors:  Jay E Gee; Claudio T Sacchi; Mindy B Glass; Barun K De; Robbin S Weyant; Paul N Levett; Anne M Whitney; Alex R Hoffmaster; Tanja Popovic
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

9.  Diversity of 16S-23S rDNA internal transcribed spacer (ITS) reveals phylogenetic relationships in Burkholderia pseudomallei and its near-neighbors.

Authors:  Andrew P Liguori; Stephanie D Warrington; Jennifer L Ginther; Talima Pearson; Jolene Bowers; Mindy B Glass; Mark Mayo; Vanaporn Wuthiekanun; David Engelthaler; Sharon J Peacock; Bart J Currie; David M Wagner; Paul Keim; Apichai Tuanyok
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

10.  Computational discovery and RT-PCR validation of novel Burkholderia conserved and Burkholderia pseudomallei unique sRNAs.

Authors:  Jia-Shiun Khoo; Shiao-Fei Chai; Rahmah Mohamed; Sheila Nathan; Mohd Firdaus-Raih
Journal:  BMC Genomics       Date:  2012-12-13       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.